Literature DB >> 26698849

Parental rheumatoid arthritis and long-term child morbidity: a nationwide cohort study.

Ane Lilleøre Rom1, Chun Sen Wu2, Jørn Olsen3, Damini Jawaheer4, Merete Lund Hetland5, Bent Ottesen6, Lina Steinrud Mørch7.   

Abstract

OBJECTIVE: To estimate the influence of parental rheumatoid arthritis (RA) on child morbidity.
DESIGN: Nationwide cohort study.
SETTING: Individual linkage to nationwide Danish registries. PARTICIPANTS: All singletons born in Denmark during 1977-2008 (n=1 917 723) were followed for an average of 16 years. MAIN OUTCOME MEASURES: Adjusted HRs for child morbidity; that is, 11 main diagnostic groups and specific autoimmune diseases within the International Classification of Diseases 8th and 10th versions.
RESULTS: Compared with unexposed children, children exposed to maternal RA ('clinical' and 'preclinical') (n=13 566) had up to 26% higher morbidity in 8 of 11 main diagnostic groups. Similar tendencies were found in children exposed to paternal RA ('clinical' and 'preclinical') (n=6330), with statistically significantly higher morbidity in 6 of 11 diagnostic groups. HRs were highest for autoimmune diseases with up to three times increased risk of juvenile idiopathic arthritis (HR, 95% CI 3.30, 2.71 to 4.03 and 2.97, 2.20 to 4.01) and increased risk of up to 40% of diabetes mellitus type 1 (HR, 95% CI 1.37, 1.12 to 1.66 and 1.44, 1.09 to 1.90) and up to 30% increased HR of asthma (HR, 95% CI 1.28, 1.20 to 1.36 and 1.15, 1.04 to 1.26). Conclusions were roughly similar for children exposed to maternal clinical RA and for children only followed up to 16 years of age.
CONCLUSION: Children of parents with RA had consistent excess morbidity. If the associations reflect biological mechanisms, genetic factors seem to play an important role. These findings call for attention given to children of parents with RA. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  Early Rheumatoid Arthritis; Epidemiology; Rheumatoid Arthritis

Mesh:

Year:  2015        PMID: 26698849      PMCID: PMC4919218          DOI: 10.1136/annrheumdis-2015-208072

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  37 in total

1.  Fetal growth and preterm birth in children exposed to maternal or paternal rheumatoid arthritis: a nationwide cohort study.

Authors:  Ane L Rom; Chun S Wu; Jørn Olsen; Hanne Kjaergaard; Damini Jawaheer; Merete L Hetland; Mogens Vestergaard; Lina S Mørch
Journal:  Arthritis Rheumatol       Date:  2014-12       Impact factor: 10.995

2.  Pregnancy and delivery in women with chronic inflammatory arthritides with a specific focus on first birth.

Authors:  Marianne Wallenius; Johan F Skomsvoll; Lorentz M Irgens; Kjell Å Salvesen; Bjorn Y Nordvåg; Wenche Koldingsnes; Knut Mikkelsen; Cecilie Kaufmann; Tore K Kvien
Journal:  Arthritis Rheum       Date:  2011-06

3.  Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births.

Authors:  G C Smith; J P Pell; D Walsh
Journal:  Lancet       Date:  2001-06-23       Impact factor: 79.321

Review 4.  Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure.

Authors:  Kerry Wright; Cynthia S Crowson; Sherine E Gabriel
Journal:  Heart Fail Clin       Date:  2014-01-10       Impact factor: 3.179

5.  Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders.

Authors:  Zeyan Liew; Beate Ritz; Cristina Rebordosa; Pei-Chen Lee; Jørn Olsen
Journal:  JAMA Pediatr       Date:  2014-04       Impact factor: 16.193

6.  Pregnancy outcomes in women with rheumatoid arthritis in Washington State.

Authors:  Susan D Reed; Teresa A Vollan; Megan A Svec
Journal:  Matern Child Health J       Date:  2006-07

7.  Rheumatoid arthritis and outcomes in first and subsequent births based on data from a national birth registry.

Authors:  Marianne Wallenius; Kjell Å Salvesen; Anne K Daltveit; Johan F Skomsvoll
Journal:  Acta Obstet Gynecol Scand       Date:  2014-01-28       Impact factor: 3.636

8.  The Danish National Hospital Register. A valuable source of data for modern health sciences.

Authors:  T F Andersen; M Madsen; J Jørgensen; L Mellemkjoer; J H Olsen
Journal:  Dan Med Bull       Date:  1999-06

9.  Familial aggregation of juvenile idiopathic arthritis.

Authors:  Sampath Prahalad; Elizabeth O'brien; Alison M Fraser; Richard A Kerber; Geraldine P Mineau; David Pratt; David Donaldson; Michael J Bamshad; John Bohnsack
Journal:  Arthritis Rheum       Date:  2004-12

10.  Familial association between type 1 diabetes and other autoimmune and related diseases.

Authors:  K Hemminki; X Li; J Sundquist; K Sundquist
Journal:  Diabetologia       Date:  2009-06-20       Impact factor: 10.122

View more
  4 in total

1.  Parental Rheumatoid Arthritis, Child Mortality, and Case Fatality: A Nationwide Cohort Study.

Authors:  Ane L Rom; Chun S Wu; Jørn Olsen; Damini Jawaheer; Merete L Hetland; Bent Ottesen; Lina S Mørch
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-05-08       Impact factor: 4.794

2.  The Danish Medical Birth Register.

Authors:  Mette Bliddal; Anne Broe; Anton Pottegård; Jørn Olsen; Jens Langhoff-Roos
Journal:  Eur J Epidemiol       Date:  2018-01-19       Impact factor: 8.082

3.  Parental rheumatoid arthritis and childhood epilepsy: A nationwide cohort study.

Authors:  Ane Lilleøre Rom; Chun Sen Wu; Jørn Olsen; Damini Jawaheer; Merete Lund Hetland; Jakob Christensen; Bent Ottesen; Lina Steinrud Mørch
Journal:  Neurology       Date:  2016-11-16       Impact factor: 9.910

4.  Chronic Inflammatory Diseases - Diabetes Mellitus, Rheumatoid Arthritis, Coeliac Disease, Crohn's Disease, and Ulcerative Colitis Among the Offspring of Affected Parents: A Danish Population-Based Registry Study.

Authors:  Vibeke Andersen; Andreas Kristian Pedersen; Sören Möller; Anders Green
Journal:  Clin Epidemiol       Date:  2021-01-07       Impact factor: 4.790

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.